Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{171172,
        author = {Rallabandi Lakshmi Pavani},
        title = {A Brief Overview of Metformin- An anti-diabetic drug to fight cancer and its Importance},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {3052-3055},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=171172},
        abstract = {Metformin is a biguanide anti – diabetic drug used in conjunction with diet and exercise for glycemic control in type -2 diabetes mellitus. It is also used off -label for insulin resistance in polycystic ovary syndrome (PCOS) .Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer incidence and mortality , many in vitro and in vivo studies as well as a large number of clinical trails have been conducted in order to study its potential .This article aim is to  provide an overview of metformin role as an anti-diabetic drug by understanding is mechanism of action , efficiency and importance and also role of metformin in the treatment of cancer.},
        keywords = {metformin, cancer, diabetes mellitus, insulin.},
        month = {December},
        }